University Of Texas Buys Elliott Opportunity II Corp, Immatics NV, Pioneer Natural Resources Co, Sells Accolade Inc, Taysha Gene Therapies Inc, Vir Biotechnology Inc

• New Purchases: EOCW.U, IMTX, PXD, WY, AAPL, UNH,
• Reduced Positions: TSHA, VT, AGLE,
• Sold Out: ACCD, VIR, DNLI, FB, TPL, UPS, AMZN, PG,

For the details of UNIVERSITY OF TEXAS's stock buys and sells, go to https://www.gurufocus.com/guru/university+of+texas/current-portfolio/portfolio

1. Taysha Gene Therapies Inc (TSHA) - 1,391,190 shares, 22.62% of the total portfolio. Shares reduced by 36.15%
2. Beam Therapeutics Inc (BEAM) - 224,391 shares, 22.15% of the total portfolio.
3. Elliott Opportunity II Corp (EOCW.U) - 2,000,000 shares, 15.36% of the total portfolio. New Position
4. Vanguard Total World Stock ETF (VT) - 158,484 shares, 12.60% of the total portfolio. Shares reduced by 6.79%
5. Codiak BioSciences Inc (CDAK) - 847,108 shares, 12.04% of the total portfolio.

University Of Texas initiated holding in Elliott Opportunity II Corp. The purchase prices were between $10.01 and $10.01, with an estimated average price of $10.01. The stock is now traded at around $9.970000. The impact to a portfolio due to this purchase was 15.36%. The holding were 2,000,000 shares as of 2021-06-30.

University Of Texas initiated holding in Immatics NV. The purchase prices were between $10.43 and $12.81, with an estimated average price of $11.72. The stock is now traded at around $11.580000. The impact to a portfolio due to this purchase was 6.21%. The holding were 697,431 shares as of 2021-06-30.

University Of Texas initiated holding in Pioneer Natural Resources Co. The purchase prices were between $145.02 and $170.71, with an estimated average price of $157.19. The stock is now traded at around $141.320000. The impact to a portfolio due to this purchase was 0.46%. The holding were 3,656 shares as of 2021-06-30.

University Of Texas initiated holding in Weyerhaeuser Co. The purchase prices were between $33.41 and $40.79, with an estimated average price of $37.09. The stock is now traded at around $34.160000. The impact to a portfolio due to this purchase was 0.03%. The holding were 1,000 shares as of 2021-06-30.

University Of Texas initiated holding in Apple Inc. The purchase prices were between $122.15 and $136.96, with an estimated average price of $129.28. The stock is now traded at around $148.190000. The impact to a portfolio due to this purchase was 0.02%. The holding were 200 shares as of 2021-06-30.

University Of Texas initiated holding in UnitedHealth Group Inc. The purchase prices were between $364.37 and $420.89, with an estimated average price of $398.06. The stock is now traded at around $429.710000. The impact to a portfolio due to this purchase was 0.01%. The holding were 25 shares as of 2021-06-30.

University Of Texas sold out a holding in Accolade Inc. The sale prices were between $38.61 and $55, with an estimated average price of $48.53.

University Of Texas sold out a holding in Vir Biotechnology Inc. The sale prices were between $38.75 and $51.27, with an estimated average price of $45.56.

University Of Texas sold out a holding in Denali Therapeutics Inc. The sale prices were between $50.3 and $78.44, with an estimated average price of $61.73.

University Of Texas sold out a holding in Facebook Inc. The sale prices were between $294.53 and $355.64, with an estimated average price of $320.19.

University Of Texas sold out a holding in United Parcel Service Inc. The sale prices were between $169.99 and $217.5, with an estimated average price of $199.41.

University Of Texas sold out a holding in Texas Pacific Land Corp. The sale prices were between $1453.12 and $1753.25, with an estimated average price of $1566.13.